ZJAMP Group Co., Ltd. (002758.SZ)
CNY 8.69
(-2.47%)
CNY 8.69
(-2.47%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.51 Billion CNY | -28.89% |
| 2022 | 2.06 Billion CNY | -0.1% |
| 2021 | 2.13 Billion CNY | 68.73% |
| 2020 | 1.26 Billion CNY | 1185.56% |
| 2019 | 370.94 Million CNY | 4.95% |
| 2018 | 100.29 Million CNY | 11.69% |
| 2017 | 85.41 Million CNY | 23.56% |
| 2016 | 68.45 Million CNY | -10.99% |
| 2015 | 78.62 Million CNY | -4.26% |
| 2014 | 79.72 Million CNY | 0.74% |
| 2013 | 78.95 Million CNY | 4.01% |
| 2012 | 75.04 Million CNY | 40.36% |
| 2011 | 54.15 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 165.01 Million CNY | 19.1% |
| 2024 Q1 | 240.06 Million CNY | -69.23% |
| 2024 Q3 | 164.14 Million CNY | -23.91% |
| 2023 Q4 | 521.58 Million CNY | 149.66% |
| 2023 Q3 | 208.91 Million CNY | -7.51% |
| 2023 Q2 | 225.88 Million CNY | -30.32% |
| 2023 FY | - CNY | -28.89% |
| 2023 Q1 | 324.19 Million CNY | -52.83% |
| 2022 FY | - CNY | -0.1% |
| 2022 Q1 | 404.6 Million CNY | -51.11% |
| 2022 Q4 | 687.28 Million CNY | 59.5% |
| 2022 Q3 | 430.9 Million CNY | 11.29% |
| 2022 Q2 | 387.18 Million CNY | -4.31% |
| 2021 Q4 | 827.55 Million CNY | 69.95% |
| 2021 Q1 | 271.34 Million CNY | -75.18% |
| 2021 FY | - CNY | 68.73% |
| 2021 Q2 | 358.73 Million CNY | 32.21% |
| 2021 Q3 | 486.93 Million CNY | 35.74% |
| 2020 Q3 | 20.04 Million CNY | 40.82% |
| 2020 Q1 | 11.27 Million CNY | 175.91% |
| 2020 FY | - CNY | 1185.56% |
| 2020 Q4 | 1.09 Billion CNY | 5355.33% |
| 2020 Q2 | 14.23 Million CNY | 26.22% |
| 2019 Q1 | 14.88 Million CNY | 6.68% |
| 2019 Q4 | 4.08 Million CNY | -77.5% |
| 2019 FY | - CNY | 4.95% |
| 2019 Q3 | 18.16 Million CNY | -23.62% |
| 2019 Q2 | 23.78 Million CNY | 59.79% |
| 2018 Q3 | 15.96 Million CNY | -13.83% |
| 2018 Q4 | 13.95 Million CNY | -12.61% |
| 2018 FY | - CNY | 11.69% |
| 2018 Q1 | 12.61 Million CNY | -3.77% |
| 2018 Q2 | 18.52 Million CNY | 46.9% |
| 2017 Q1 | 15.11 Million CNY | -15.34% |
| 2017 FY | - CNY | 23.56% |
| 2017 Q4 | 13.1 Million CNY | -21.78% |
| 2017 Q3 | 16.75 Million CNY | -16.69% |
| 2017 Q2 | 20.11 Million CNY | 33.1% |
| 2016 Q2 | 15.44 Million CNY | 22.17% |
| 2016 Q3 | 13.3 Million CNY | -13.85% |
| 2016 Q4 | 17.85 Million CNY | 34.19% |
| 2016 FY | - CNY | -10.99% |
| 2016 Q1 | 12.63 Million CNY | -35.66% |
| 2015 Q4 | 19.64 Million CNY | 22.28% |
| 2015 Q2 | 15.16 Million CNY | 4.89% |
| 2015 Q1 | 14.45 Million CNY | -31.36% |
| 2015 FY | - CNY | -4.26% |
| 2015 Q3 | 16.06 Million CNY | 5.95% |
| 2014 FY | - CNY | 0.74% |
| 2014 Q4 | 21.05 Million CNY | 31.96% |
| 2014 Q1 | 17.62 Million CNY | 0.0% |
| 2014 Q3 | 15.95 Million CNY | 13.16% |
| 2014 Q2 | 14.1 Million CNY | -19.98% |
| 2013 FY | - CNY | 4.01% |
| 2012 FY | - CNY | 40.36% |
| 2011 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 912.84 Million CNY | -65.966% |
| Yixintang Pharmaceutical Group Co., Ltd. | 2.18 Billion CNY | 30.571% |
| Luyan Pharma Co.,Ltd. | 819.73 Million CNY | -84.818% |
| Ji Yao Holding Group Co., Ltd. | -225.02 Million CNY | 773.261% |